Sientra logo
Sientra SIEN
report update icon

Quarterly report 2023-Q3
added 05-16-2026

Sientra Income Statement 2022-2011 | SIEN

Brief overview of revenue and earnings at Sientra

The comparison covers a five-year financial horizon. The revenue attributed to Sientra moved from $36.5 million to $25.1 million between the two endpoints. The total change was −31.4%, with a CAGR of approximately −7.3%. The business finished the period with a smaller revenue base.

The gross result shifted from $22.4 million to $3.2 million, or −85.6%. The cost base moved against the top-line trend and weighed on the gross result. Gross margin moved from 61.2% to 12.9%. Weakening gross profitability reduces the quality of the top-line trend.

The operating result measured by EBITDA moved from −59.9 million dollars to −62.4 million dollars, or −4.3%. Additional revenue translated efficiently into EBITDA. EBITDA margin was −163.8% at the start and −249% at the end. Operating return per unit of revenue declined.

The net financial result changed from −$64 million to −$22 million. The negative result improved without reaching break-even.

Overall conclusion

Signs of deterioration dominate the five-year picture. The strongest signals are net-income growth. The weaker side of the profile includes weaker gross profitability, a narrow EBITDA buffer and weak sales momentum. Further direction will depend on top-line growth, operating profitability, and net income.

Annual Income Statement Sientra

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- 20.9 M 19.5 M 363 M 323 M 269 M 155 M 93.4 M 42.7 M - - -

Shares

7.18 M 5.71 M 5.02 M 40.7 M 25.4 M 19.2 M 18.2 M 15.8 M 2.55 M 233 K 276 K -

Historical Prices

- 3.67 3.89 8.94 12.7 14.1 8.52 5.92 16.8 - - -

Net Income

-22 M -16.1 M -89.9 M -107 M -82.6 M -64 M -40.2 M -41.2 M -5.81 M -19.1 M -23.4 M -

Revenue

25.1 M 22.6 M 55 M 46.4 M 68.1 M 36.5 M 20.7 M 38.1 M 44.7 M 35.2 M 10.4 M -

Cost of Revenue

49 M 36.3 M 23.6 M 16.4 M 26.8 M 14.2 M 6.88 M - - - - -

Gross Profit

3.23 M 12.3 M 31.4 M 30 M 41.3 M 22.4 M 13.9 M 27.5 M 33.2 M 26.6 M 8.1 M -

Operating Income

-69 M -46.4 M -47.4 M -54.9 M -79.8 M -62.9 M -40 M -38.5 M -5.78 M -18.2 M -23.4 M -

Interest Expense

9.11 M 8.25 M 9.44 M 4.57 M 3.43 M 1.23 M 98 K 3.1 M 2.17 M 872 K -1 K -

EBITDA

-62.4 M -42 M -44 M -53.2 M -76.5 M -59.9 M -38.9 M -38.2 M -5.51 M -17.9 M -23.1 M -

Operating Expenses

111 M 90.7 M 78.8 M 84.9 M 121 M 85.3 M 53.9 M 66 M 39 M 44.8 M 31.5 M -

General and Administrative Expenses

41.5 M 31.8 M 32.3 M 36.4 M 42.4 M 31.5 M 22 M 18.7 M 10.7 M 18.1 M 9.94 M -

All numbers in USD currency

Quarterly Income Statement Sientra

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

11.3 M 11.2 M 12.2 M 10.7 M 62.8 M 62.6 M 62.3 M 62.2 M 58 M 57.6 M 54.3 M 50.6 M 50.4 M 50.1 M 49.9 M 49.5 M 49.4 M 34.3 M 29.1 M 28.6 M 28.5 M 24.8 M 19.6 M 19.4 M 19.3 M 19.1 M 18.8 M 18.6 M 18.2 M 18.1 M 18.1 M 18 M 15.2 M 14.9 M 14.9 M 14.9 M 209 K 209 K 208 K 207 K 206 K - - - - - - - - - -

Net Income

-14.8 M -9.48 M -12.9 M - -15 M -18.3 M -18 M - 28.4 M -20.1 M -54.7 M -21.2 M -5.82 M -34.3 M -28.6 M -20.2 M -22.4 M -37.7 M -26.5 M -24.6 M -20.5 M -18 M -19.4 M -17.8 M -14.4 M -20.4 M -11.4 M -8.07 M -9.96 M -10.2 M -11.9 M -28.2 M -6.6 M -2.99 M -3.38 M -3.2 M -1.45 M -160 K -1 M -3.08 M -6.48 M -5.46 M -4.11 M - - - - - - - -

Revenue

19.5 M 23.1 M 22.6 M - 22.6 M 21.5 M 21.4 M - 19.6 M 20.1 M 23.2 M 22.6 M 19.2 M 12.4 M 16.9 M 23.2 M 22.4 M 20.5 M 17.6 M 19 M 16.9 M 17.6 M 14.7 M 11.1 M 9.82 M 8.17 M 7.49 M - 6.53 M - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

9.52 M 10.5 M 10.4 M - 9.79 M 8.77 M 8.55 M - 9.03 M 8.84 M 10.9 M - 8.39 M 5.55 M 6.79 M - 9.75 M 7.81 M 6.47 M - 6.4 M 6.66 M 6.1 M - 3.48 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

10 M 12.6 M 12.1 M - 12.8 M 12.7 M 12.8 M - 10.6 M 11.3 M 12.3 M 11.1 M 10.8 M 6.9 M 10.1 M 14.2 M 12.7 M 12.7 M 11.1 M 11.4 M 10.5 M 10.9 M 8.58 M 5.32 M 6.34 M 5.55 M 5.17 M 3.93 M 4.72 M 4.5 M 711 K 990 K 7 M 10.3 M 9.2 M 8.9 M 7.84 M 8.84 M 7.65 M 7.01 M 6.01 M 7.07 M 6.49 M - - - - - - - -

Operating Income

-9.4 M -7.11 M -10.6 M - -12.6 M -15.9 M -16.1 M - -11.7 M -9.16 M -9.82 M - -14 M -12.3 M -27 M - -21.5 M -37 M -25.9 M - -19.6 M -16.9 M -18.9 M - -13.9 M -20.2 M -11.4 M - -9.77 M -10.2 M -11.9 M - -5.57 M -2.12 M -2.63 M - -753 K -1.2 M -1.38 M - -6.23 M - - - - - - - - - -

Interest Expense

2.37 M 2.51 M 2.38 M - 2.36 M 2.32 M 1.9 M - 2.03 M 2.11 M 2 M - 2.06 M 3.61 M 1.62 M - 1.34 M 982 K 952 K - 953 K 867 K 655 K - 409 K 185 K 9 K - 105 K 12 K 1 K - 1.61 M 671 K 668 K - 665 K 411 K 431 K - 232 K - - - - - - - - - -

EBITDA

-3.85 M -3.43 M -8.72 M - -7.61 M -12.5 M -14.4 M - -8.54 M -7.05 M -8.44 M - -11 M -10.6 M -25.8 M - -18.9 M -35.2 M -25 M - -17.1 M -15.2 M -18 M - -11.8 M -19.1 M -10.8 M - -9.04 M -9.78 M -11.8 M - -5.34 M -1.97 M -2.55 M - -557 K -1.08 M -1.32 M - -6.02 M - - - - - - - - - -

Operating Expenses

19.4 M 19.7 M 22.7 M - 25.3 M 28.7 M 28.9 M - 22.3 M 20.4 M 22.1 M - 24.8 M 19.2 M 37.1 M - 34.1 M 49.7 M 36.9 M - 30 M 27.8 M 27.5 M - 20.2 M 25.8 M 16.6 M - 14.5 M 14.7 M 12.6 M - 12.6 M 12.4 M 11.8 M - 8.59 M 10 M 9.03 M - 12.2 M - - - - - - - - - -

General and Administrative Expenses

7.62 M 7.33 M 9.85 M - 9.32 M 12.1 M 10.2 M - 7.86 M 7.54 M 7.35 M - 10.2 M 7.96 M 9.3 M - 12.2 M 11.8 M 13.5 M - 11.9 M 10 M 9.5 M - 9.3 M 8.02 M 6.44 M - 7.3 M 5.36 M 5.29 M - 4.14 M 3.94 M 3.72 M - 2.63 M 2.64 M 2.27 M - 6.3 M - - - - - - - - - -

All numbers in USD currency

The income statement is one of the three key financial reports of a company Sientra (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 57.08 3.84 % $ 8.66 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 15.55 0.18 % $ 440 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.8 6.24 % $ 642 M israelIsrael
Electromed Electromed
ELMD
$ 29.6 0.27 % $ 245 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.71 0.69 % $ 12 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 80.32 0.36 % $ 4.38 B britainBritain
LENSAR LENSAR
LNSR
$ 8.3 0.24 % $ 99.3 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.34 0.15 % $ 21.2 M usaUSA
SmileDirectClub SmileDirectClub
SDC
- -53.45 % $ 9.71 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
ShockWave Medical ShockWave Medical
SWAV
- - $ 12.3 B usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Butterfly Network Butterfly Network
BFLY
$ 8.43 0.93 % $ 2.08 B usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 125.33 0.02 % $ 4.35 B usaUSA